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BACKGROUND OF THE INVENTION 
The present invention relates to microfluidic devices. In 
one example, the present invention provides microfluidic 
control structures for effectively implementing sample prepa- 
ration, processing, detection and analysis systems. 
Conventional mechanisms for microfluidic analysis are 
limited. Some available mechanisms include single channel 
separation devices and multiple channel separation devices. 
Others include analyzers that integrate some sample prepa- 
ration and analysis steps. However, many microfluidic analy- 
sis devices that include fluidic control capabilities are chemi- 
cally or physically incompatible with many chemical or 
biochemical assays. In addition, many microfluidic control 
elements are difficult to fabricate in dense arrays because of 
limitations in the fabrication process, robustness, and/or 
design. Many conventional devices require constant actuation 
to maintain fluidic control. A microfluidic device utilizing 
such valves can not be removed from its control system with- 
out losing control of the fluidic contents of the device. In 
addition, many techniques and mechanisms for microfluidic 
analysis furthermore lack sensitivity, specificity, or quantita- 
tive analysis capabilities. In particular, conventional microf- 
luidic analysis mechanisms lack the functionality and capa- 
bilities to efficiently implement sample preparation for 
systems such as pathogen detectors and analyzers. 
It is therefore desirable to provide improved methods and 
apparatus for implementing micro fluidic control mechanisms 
suchas valves, pumps, routers, reactors, etc. to allow effective 
integration of sample introduction, preparation processing, 
and analysis capabilities in a microfluidic device. In one 
example, it is desirable to provide microfluidic devices hav- 
ing microfabrication efficiencies that can be used to imple- 
ment both single channel and array based systems that can be 
used as pathogen detectors and analyzers that provide few 
false positives, high throughput and inexpensive continuous 
monitoring. 
2 
SUMMARY OF THE INVENTION 
Methods and apparatus for implementing microfluidic 
analysis devices are provided. A monolithic elastomer mem- 
5 brane associated with an integrated pneumatic manifold 
allows the placement and actuation of a variety of fluid con- 
trol structures, such as structures for pumping, isolating, mix- 
ing, routing, merging, splitting, preparing, and storing vol- 
umes of fluid. The fluid control structures can be used to 
i o  implement a variety of sample introduction, preparation, pro- 
cessing, and storage techniques. 
In one embodiment, a microfluidic structure is provided. 
The microfluidic structure includes a first surface, a second 
surface, and an elastomer membrane. The first surface 
15 includes a pneumatic channel. The second surface includes a 
fluidic channel. An elastomer membrane is located between 
the first and second surfaces such that the application of a 
pressure or a vacuum to the pneumatic channel causes the 
membrane to deflect to modulate a flow of a fluid in the fluidic 
In another embodiment, a microfluidic structure is pro- 
vided. A first layer includes a pneumatic channel. A second 
layer includes a plurality of vias. A third layer includes a 
fluidic channel. An elastomer membrane is located between 
25 the first and second layers such that the application of a 
vacuum to the pneumatic channel causes the membrane to 
deflect to modulate a flow of a fluid in the fluidic channel. 
In another embodiment, a microfluidic device is provided. 
The microfluidic devices includes a chemically compatible 
30 layer and a membrane layer. The chemically compatible layer 
has a plurality of channels. The channels are operable to 
provide paths for fluid flow. A membrane layer is coupled to 
the chemically compatible layer. Applying pneumatic pres- 
sure to regions of the membrane layer is operable to actuate a 
35 plurality of pneumatically switchable valves, wherein the 
pneumatically switchable valves are operable to control fluid 
flow on the microfluidic device. 
In yet another embodiment, a method for controlling fluid 
flow on a microfluidic device is provided. An input valve is 
40 opened and an output valve is closed by varying pneumatic 
pressure to one or more regions of a membrane layer coupled 
to a glass layer. The glass layer includes a plurality of etched 
channels. The etched channels are operable to provide paths 
for fluid flow. A diaphragm valve is opened and the input 
45 valve is closed by varying pneumatic pressure. The output 
valve is opened and the diaphragm valve is closed. Closing 
the diaphragm valve pumps analyte fluid through the open 
output valve. 
These and other features and advantages of the present 
50 invention will be presented in more detail in the following 
specification of the invention and the accompanying figures, 
which illustrate by way of example the principles of the 
invention. 
20 channel. 
55 BRIEF DESCRIPTION OF THE DRAWINGS 
The invention may best be understood by reference to the 
following description taken in conjunction with the accom- 
panying drawings, that illustrate specific embodiments ofthe 
FIGS. 1A-1E are diagrammatic representations showing 
mechanisms on a microfluidic device suitable for implement- 
ing the techniques of the present invention. 
FIG. 2 is a diagrammatic representation depicting a dia- 
FIG. 3 is a plan view of a diagrammatic representation 
60 present invention. 
65 phragm pump. 
showing a fluidic router. 
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FIG. 4 is a plan view of a diagrammatic representation microfluidic device requires a robust on chip mechanism for 
isolating, routing, merging, splitting, and storing volumes of 
FIGS. 5A-5D are diagrammatic representations showing a fluid. 
Some valve technologies for use in silicon, glass silicon, 
FIG. 6 is a diagrammatic representation showing bus 5 polymer, and elastomer microfluidic devices have addressed 
these requirements in a limited manner. However, many of 
FIG. 7 is a diagrammatic representation of a pathogen these technologies are chemically or physically incompatible 
with many chemical or biochemical assays. Furthermore, 
FIG. 8 is a diagrammatic representation depicting immu- many technologies lack the variety of robust surface modifi- 
i o  cation chemistries available for glass microfluidic devices. In 
depicting a mixing loop. 
fluid reservoir. 
valves. 
detection system. 
noaffinity capture valve mechanisms. 
FIG. 9 is a diagrammatic representation showing immu- 
noaffinity capture valve mechanisms. 
FIGS. 10A and 10B are diagrammatic representations 
showing capture and routing of analytes for immunoaffinity 
capture. 
FIG. 11 is a diagrammatic representation showing PCR 
and CE that can be integrated with immunoaffinity capture. 
FIG. 12 is a diagrammatic representation of a combined 
immunocapture and PCR chamber. 
FIG. 13A is a diagrammatic representation of a pathogen 
addition, individual microfluidic valves are typically fabri- 
cated with separate membranes normally held open. Having 
valves normally open requires constant actuation to maintain 
fluidic control. A microfluidic device utilizing such valves 
15 cannot be removed from a control system without losing 
control of the fluidic contents of the device. Furthermore, 
some typical devices use individually placed latex mem- 
branes. Individually placed pneumatically actuated latex 
membranes haven been developed but this fabricationmethod 
20 prevents large scale integration into multichannel, high 
detection system. throughput analysis devices. 
fabrication stages. 
of pathogen detection systems. 
FIG. 13B is a diagrammatic representation showing micro- 
FIG. 14 is a diagrammatic representation of a radial array 
Other microfluidic devices are fabricated using anodically 
bonded silicon and glass wafers and actuated piezoelectri- 
cally. However, the electrical conductivity and chemical com- 
25 patibility of silicon complicates use in analytical devices. 
Thin films bonded to or deposited on silicon can only partially 
mitigate the electrical conductivity and chemical compatibil- 
Elastomer devices have also been demonstrated. However, 
Reference will now be made in detail to some specific 30 the hydrophobicity and porosity of elastomeric materials ren- 
embodiments of the invention including the best modes con- der elastomeric devices incompatible with many chemical 
and biochemical assays. It is thus desirable to minimize the 
Examples of these specific embodiments are illustrated in the fluidic contact with elastomer surfaces. complex fabrication, 
accompanying drawings. While the invention is described in chemical compatibility, unreliable fluid manipulation and 
conjunction with these specific embodiments, it will be 35 other problems have made existing fluidic manipulation tech- 
understood that it is not intended to limit the invention to the nologies inadequate for integration into large-scale, high- 
described embodiments. On the contrary, it is intended to throughput lab-on-a-chip devices. 
cover alternatives, modifications, and equivalents as may be Consequently, the techniques and mechanisms of the 
included within the spirit and scope of the invention as present invention provide a monolithic membrane valve 
defined by the appended claims. For example, the techniques 40 structure suitable for high density integration into microflu- 
of the present invention will be described in the context of idic devices. A variety of fluid control structures based on the 
glass microfluidic devices, although other devices such as monolithic membrane valve structures are also provided. 
plastic devices could also be used. A microfluidic device having a monolithic membrane is 
It should be noted that the fluid control structures suitable one example of a particularly suitable device for implement- 
for use in glass microfluidic devices can be applied to a 45 ing a pathogen detection system on a chip. According to 
variety of microfluidic devices. A pathogen detection system various embodiments, the pathogen detection system 
is a good example of one possible application that can benefit includes immunocapture and DNA analysis mechanisms 
from the use of fluid control structures. In the following such as polymerase chain reaction (PCR), and capillary elec- 
description, numerous specific details are set forth in order to trophoresis (CE) mechanisms. In one example, the pathogen 
provide a thorough understanding of the present invention. 50 detection system can be implemented on a glass microfluidic 
The present invention may be practiced without some or all of device having a variety of fluidic control structures. 
these specific details. In other instances, well known process FIGS. 1A-1E are diagrammatic representations of mono- 
operations have not been described in detail in order not to lithic membrane valves that can be implemented on a glass 
unnecessarily obscure the present invention. microfluidic device. FIG. 1A is a top view of a diagrammatic 
The field of microfluidic analysis technology has evolved 55 representation of a monolithic membrane valve. FIG. 1B is a 
rapidly from the earliest single channel separation devices. side view of a diagrammatic representation of a three-layer 
Some devices include multichannel separation devices for device having the valve. FIG. 1C is a side view of a diagram- 
high throughput analysis and analyzers that integrate sine matic representation of a four-layer devices having the valve. 
sample preparation and analysis on a single chip. Devices that FIG. 1D is a side view of a diagrammatic representation of an 
combine both multichannel analysis and integrated sample 60 open valve of a three-layer device. FIG. 1E is a side view of 
preparation are capable of reducing the amount of resources aidagrammatic representation of an open valve four-layer 
and cost needed to perform a variety of assays. An illustrative device. According to various embodiments shown in FIGS. 
example may be found in the field of genomics: integration of 1Aand lB,  a three-layer glass microfluidic device includes an 
sequencing sample preparation, purification, and electro- elastomer membrane 111 sandwiched between two glass 
phoretic analysis ina single device translates into decreases in 65 wafers 101 and 105. In one example, the elastomer membrane 
assay time and cost and increased assay throughput efficiency is a polydimethysiloxane (PDMS) membrane available as 
and robustness. In all cases, a high level of integration in a 254 pm thick HT-6135 and HT-6240 membranes from Bisco 
DETAILED DESCRIPTION OF SPECIFIC 
EMBODIMENTS ity. 
ternplated by the inventors for cawing out the invention. 
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Silicons of Elk Grove, Ill. Other flexible membranes can also benefits over a three layer device as it minimizes contact 
be used. The elastomer membrane 111 makes a reversible but between a sample and an elastomer membrane in some cases 
strong bond between the wafers. to only a valve area 161. 
A fluidic channel 103 is etched in the wafers prior to It should be noted that the structures shown can be oriented 
bonding and is used to carry fluids. A manifold channel 107 5 in any direction. In some examples, valves can be inverted on 
and a valve area 109 are similarly etched to carry air or other a device. A pneumatic layer can be above or below a fluidic 
working fluid under pressure or vacuum to actuate the valves. layer. The techniques of the present invention allow a variety 
Typically, the pneumatic channels 107 and 109 are located on of orientations, as gravity does not adversely affect the mem- 
one wafer 105, herein referred to as the pneumatic wafer, and brane valves. 
the fluidic channels are etched on the second wafer 101, i o  The fluidic control structures provide a variety ofbenefits. 
herein referred to as the fluidic wafer. These etched channel For example, the monolithic membrane valves are normally 
features can directly contact the membrane and form a hybrid closed valves, meaning that the valves remain closed even 
glassielastomer channel as shown in FIG. 1B. when the device is disconnected from the actuation pressure 
Alternatively, the membrane can be between a thermally source. Existing normally open microfluidic valves require 
bonded all-glass fluidic wafer sandwich (XU) and the pneu- 15 constant actuation to maintain control of the fluidic contents 
matic wafer 159 as shown in the four-layer device 150 of FIG. of the device. Furthermore, unlike shape memory alloy struc- 
1C. Having an all glass channel allows a device to benefit tures, both the closed and open temperatures of the valve 
from the favorable physical and chemical properties of glass. structures are at ambient temperature, facilitating work with 
Any layer having favorable physical and chemical properties aqueous biological fluids. 
is referred to as a chemically inactive layer. The chemically 20 In many typical implementations, a number of interfaces 
inactive layer can be used to fabricated XY. In one example, between the microfluidic device are needed in order to 
the sandwich of 151 and 155 that constitutes XY is made of manipulate various fluidic control mechanisms. However, 
glass. according to various embodiments of the present invention, 
An example of a four layer devices includes a fluidic wafer multiple regions of a membrane can be actuated in parallel by 
151 thermally bonded to a via wafer 155. Via holes with small 25 connecting their pneumatic control channels. In one example, 
diameters are placed at the discontinuity in the fluidic channel a series of valves can be controlled using a single pneumatic 
153. The elastomer membrane 157 is affixed to the via wafer port. Consequently, a significant number of valves can be 
155 side of the fluidicivia wafer sandwich XZ. Valve deflec- controlled using only a limited number of external interfaces 
tion chambers 161 are etched in the manifold wafer 159 and or pneumatic ports. This simplifies implementation andmini- 
bonded to the membrane 157, completing the 4-layer device 30 mizes problems interfacing with the device. According to 
150. In this way, fluidic channel 153 retain san all-glass various embodiments, controlling valves in this manner 
chemically favorable configuration while allowing imple- allows massively parallel pneumatic actuation of a mono- 
mentation of the large-scale integrated fluidic control struc- lithic membrane for operating valves, pumps, reservoirs, 
tures. In some embodiments, the four layer device shown in routers, and other fluid control structures within the device. 
FIG. 1C provides substantial benefits over a three layer device 35 The membrane valves can be used to form a variety of 
as it minimizes contact between a sample and an elastomer fluidic control mechanisms. FIGS. 2A and 2B are diagram- 
membrane. matic representations of a pump formed using membrane 
According to various embodiments, the various fluid con- valves. According to various embodiments shown in FIGS. 
trol components within the monolithic membrane device are 2A and 2B, three valves placed in series form a diaphragm 
actuated by applying pressure or vacuum to holes on the 40 pump 210. Pumping is achieved by actuating the valves 
pneumatic wafer. Any single membrane is referred to herein according to a five step cycle. FIG. 2A shows a top view of a 
as a monolithic membrane. Any single device with a mono- three-layer monolithic membrane diaphragm pump. FIG. 2B 
lithic membrane is referred to herein as a monolithic device. shows a side view of the three-layer monolithic membrane 
Mechanisms for supplying pressure or vacuum to etched diaphragm pump. The diaphragm pump includes an input 
channels associated with a pneumatic wafer are herein 45 valve 201, a diaphragm valve 203, and an output valve 205. It 
referred to as ports or pneumatic ports. In a three layer device, should be noted that the diaphragm pump can operate in either 
etched channels in the pneumatic wafer distribute the actua- direction and the designations of the input valve and output 
tion vacuum to valve region 109 of the elastomer membrane valve are arbitrary. The pump includes a fluidic layer 209 
111. Vacuum applied via the manifold channel at valve area having etched fluidic channels 211, a monolithic membrane 
region 109 deflects the membrane away from the channel 50 207, and a manifold layer 213. The air tight nature of the 
discontinuity, providing a path for fluid flow across the dis- valves makes the pumps self-priming andcapable ofpumping 
continuity and thus opening the valve as shown in FIG. 1D. air in addition to other gases and fluids. 
Valves that can be opened or closed using pneumatic pressure According to various embodiments, pumping can be per- 
are herein referred to as switchable valves or pneumatically formed in a-series of stages. In a first stage, output valve 205 
switchable valves. 55 is closed and an input valve 201 is opened. In a second stage, 
Applying pneumatic pressure includes either applying a diaphragm valve 203 is opened. In a third stage, the input 
pressure or applying a vacuum. The membrane 157 conse- valve 201 is closed. In a fourth stage, the output valve 205 is 
quently can modulate the flow of fluid in the adjacent fluid opened. In a fifth stage, the diaphragm valve 203 is closed, 
channel as shown inFIG. 1D. In FIG. lD,  a vacuum is applied pumping analyte fluid through the open output valve 205. 
to valve area 109 through etched channels associated with 60 The volume pumpedper cycle is determined by the volume 
pneumatic wafer 105 to open fluidic channel 103. When contained within the open diaphragm valve, a volume that, in 
vacuum pressure or suction is no longer applied to valve area turn, determined by the size of the pneumatic chamber in the 
109, the membrane 111 closes the fluidic channel 103 as diaphragm valve. Therefore, pumps designed for metering 
shown in FIG. 1B. FIG. 1E shows a four layer device. The known nanoliter to microliter scale volumes of fluid can be 
four layer device includes a channel layer 151, channel 153, 65 fabricated by modulating the size of the diaphragm valve 
via layer 155, membrane layer 157, and pneumatic layer 159. pneumatic chamber. The diaphragm pumps are self-priming 
As noted above, the four layer device provides substantial and can pump fluids forward or backward by reversing the 
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actuation cycle. It should also be noted that the valve seat FIG. 5D shows a reservoir 503 connected to a pump. The 
where the membrane contacts the glass sealing surface may reservoir is filled or emptied depending upon the direction of 
be etched to have ridges or other surface modifications to pumping and has the advantage of variable volume. In one 
control the adhesion of the membrane to the glass surface. example, pumps such as valves 531,533, and 535 and be used 
Monolithic valves can also be used to form routers, merg- 5 to fill or dispense fluid for reservoir 503. 
ers, and splitters. It should be noted that although the follow- A monolithic membrane reservoir with one or more fluidic 
ing structures will be described in the context of three layer inputs functions as an on-chip reactor. Like the reservoir, the 
structures, the structures can also be implemented using four reactor can draw in reactants and expel products directly by 
or more layers. FIG. 3 is a diagrammatic representation of a using direct pressure or vacuum applied through the pneu- 
router 300. The router includes valves 301,303,305, and317; i o  matic manifold wafer. Alternatively, the reactor can draw in 
pneumatic channels 331, 333, 335, 337, and 339; fluidic reactants and expel products indirectly using an integrated 
channels 321,323,325, and 327; and a diaphragm valve 309. pump, mixer, andor router structures. According to various 
The router pumps fluid from any input to any output depend- embodiments, since the volume of the reactor is defined by 
ing upon which ofthe inputioutput valves are actuated at what the size of the chamber 503 in the pneumatic wafer, reactors 
point during the pumping cycle. Actuating two or more input 15 with arbitrary volumes can be included at any point on a 
valves simultaneously merges several different fluid streams device without drastically changing the layout of structures in 
into one stream at the output valve. Conversely, actuating two the fluidic wafer. Also, the reactor can be partially filled as 
or more output valves simultaneously splits a single fluid necessary for on chip reactions that involve a variable volume 
stream into several different streams at the output valves. of reactants . 
Most elastomer membranes are gas permeable, and this 
321, valves 301 and 305 are held closed. Valves 317,309, and property has thus far beenused to simplify fluidic filling of all 
303 can then be used as a pump as noted above. The router elastomer devices. 
includes functionality to merge and split fluid channels. To According to various embodiments, the gas permeability 
merge fluid from channels 325 and 327 into channel 323, ofthemembranecaneliminate bubbles andairpockets. When 
valve 303 is held closed. To split fluid from channel 321 to 25 applying an actuating vacuum to a monolithic membrane 
channels 323 and 327, valve 301 is held closed. In yet another reactor, or other fluidic structure, bubbles can be eliminated 
example, to route a fluid introduced through channel 327 to from reactions that produce gas. For example, the gas perme- 
channel 325, valves 303 and 305 are held closed. Valves 317 able membrane can reduce bubbles that can form during on 
and 301 can be opened to allow flow of a fluid through chip thermal cycling of PCR reactants that could result in loss 
channel 327 to channel 325. A variety of arrangements are 30 of containment of the reaction mixture. 
possible. A complex microfluidic device may include several inde- 
Amixing loop can also be formedusing monolithic valves. pendent modules connected to a fluidic bus. In one example, 
In one example, mixing can be performed by moving a fluid it may be useful to provide an analyte fluid to multiple differ- 
between two areas of a device. Mixing can be used for per- ent fluidic channels. In another example, a variety of reagents 
forming all types of on-chip operations. FIG. 4 is a diagram- 35 can be available for introduction into a microfluidic device. 
matic representation of a mixing loop 400. The mixing loop FIG. 6 is a diagrammatic representation of a bus valve 600 
or mixer includes valves 401, 403, and 405; fluidic channels that can be used to distribute an analyte fluid. The bus valve 
411, 413, and 415; and pneumatic channels 421, 423, and valve 600 includes valves 601, 603, 605, and 607 that are 
425. Additional valved channels connect to the loop and designed to route fluids from a fluidic bus channel 611 to 
provide fluidic access to or from the mixer. Two or more 40 fluidic channels 621, 623, 625, and 627. Pneumatic channels 
volumes of fluids can be admitted into the mixer loop through 631, 633, 635, and 637 manage the valves for controlling 
channels 413 and 415 and pumped, as noted above, in a circle distribution of the fluid. Typical bus valve implementations 
until the fluids are mixed by diffusion. The mixture can then have dead volume on the bus side. Dead volume makes it 
be pumped out of the mixer loop. Mixing can also be accom- difficult to rinse the bus completely between fluid routing 
plished by moving a fluid back and forth between two reser- 45 operations. According to various embodiments, the tech- 
voirs. niques of the present invention provide bus valves with little 
FIGS. 5A-5C are diagrammatic representations of a reser- or no dead volume on the bus side. This allows the bus to be 
voir 500. FIG. 5A is a top view of a reservoir with an etched rinsed completely between fluid routing operations and pre- 
displacement chamber. FIG. 5B is a side view of the reservoir. vents mixing or cross contamination between different fluids 
FIG. 5C is a side view showing a filled reservoir. FIG. 5D is 50 during device operation. 
a side view of a large-volume reservoir with drilled displace- The microfluidic device mechanisms can be fabricated 
ment chamber and pump for autonomous fillingldispensing. using a variety oftechnologies. According to various embodi- 
The reservoir is included on a pneumatic wafer 513 sand- ments, channel features are etched into glass wafers, for 
wiching a membrane SOS with a fluidic wafer 511. The example, using standard wet chemical etching. Glass wafers 
reservoir can be filled or emptied through channel 501. 55 (1.1 mm thick, 100 mm diameter) are piranha cleaned (20:l) 
According to various embodiments, an open monolithic and coated with a sacrificial (200 nm) polysilicon etch mask 
membrane valve in valve area 503 functions as a reservoir for layer using an LPCVD furnace or sputtering system. Borof- 
on chip fluid storage. The size of the chamber in the pneu- loat glass wafers or Schott D263 borosilicate glass wafers are 
matic wafer 513 determines the volume of fluid stored inside used for devices with the three-layer or four-layer design. 
the reservoir; applying vacuum fills the reservoir and apply- 60 After polysilicon deposition, the wafers are spin-coated with 
ing pressure empties it. positive photoresist, soft-baked, andpatternedusing a contact 
According to various embodiments, reservoirs for storing aligner. W-exposed regions of photoresist are removed in 
large volumes of fluid can be fabricated by replacing the Microposit developer. The exposed regions of polysilicon are 
etched pneumatic chamber with a drilled hole and applying removed by etching in SF6 plasma. The wafers are etched 
actuation pressure orvacuum directly to the hole. Alternately, 65 isotropically at 7 pnimin in HF solution (49% HF for the 
a reservoir without a direct pneumatic connection can be Borofloat wafers and 1:1:2 HF:HCI:H20 for the D263 
fabricated by connecting the reservoir to a diaphragm pump. wafers) until the desired etch depth is reached. 
For example, to route fluid from channel 327 to channel 20 
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According to various embodiments, the fluidic channel sporesil). The most advanced detection concept uses real 
wafers are etched 20 pm deep for the three-layer devices and time detection of PCR products performed in a silicon 
40 pn deep for the four-layer devices. The manifold wafers microreactor with thin film heaters and integral fluorescence 
are etched 70 pm deep for the three-layer devices and drilled excitation and detection. This system has subsequently been 
at valve locations for the four-layer devices. The remaining 5 extended to a ten channel Advanced Nucleic Acid Analyzer 
photoresist and polysilicon is then stripped from the wafers (ANAA) as well as a portable version. Versions of this system 
using PRS-3000 and SF plasma, respectively. Access holes are also being developed for the military and for the Post 
through the fluidic and manifold wafers are drilled and the Office. A GeneXpert sample preparation system with inte- 
wafers are again piranha cleaned. grated (multimicroliter) sample processing for real time PCR 
are assembled by applying a PDMS membrane (254 pm thick The development of portable analyzers that can rapidly 
HT-6135 and HT-6240, Bisco Silicones, Elk Grove, Ill.) over perform automated and complex up front chemistries and 
the etched features in the fluidic channel wafer and pressing quantitate pathogen concentrations and antibiotic resistance 
the manifold hybrid glass-PDMS fluidic channels with valves would be a major step forward. Similarly the ability to detect 
located wherever a drilledor etcheddisplacement chamber on 15 and type large numbers of samples rapidly and with very low 
the manifold was oriented directly across the PDMS mem- false positives in a high throughput, multisample screening 
brane from a valve seat. Devices utilizing the four-layer application would also be useful when large numbers of 
design are assembled by first thermally bonding the fluidic samples or potentially infected individuals need to be 
channel wafer to a 210 pm thick D263 via wafer with pairs of screened, Steps toward such automated clinical analyzers 
254 pm diameter drilled via holes positioned to correspond to 20 have been made. In one example, complex microfluidic cir- 
the locations of channel gaps. The fluidic channel and via cuit systems for blood clinical analyses that are essentially 
wafers are bonded by heating at 570 C for 3.5 h in a vacuum micro versions ofthe common autoanalyzer have been devel- 
furnace (J. M. Ney, Yucaipa, Calif.). The resulting two-layer oped. A fully integrated analyzer (microliter volume scale) 
structure containing all-glass channels is then bonded to the that was used for preparation of samples from blood for HIV 
PDMS membrane and the manifold wafer. The glass-PDMS 25 analysis onmicroarrays has also beendeveloped. This system 
bonds formed in this manner are reversible but still strong performed a complex assay including a large number of 
enough to survive the range of vacuum and pressures exerted nucleic acid steps and exploited the >lo0 nL dead volume 
on the device. Optionally, an irreversible glass-PDMS bond pneumatic membrane valves which will be discussed inmore 
are obtained by cleaning the manifoldwafer and PDMS mem- detail below. 
brane in a W ozone cleaner (Jelight Company Inc., Irvine, 30 A lucite microfluidics cube has been developed for con- 
Calif.) prior to assembly. trolling the flow of solutions over six different immunoarray 
The microfluidic device mechanisms described above can sensors that provide fluid control with a simple pressure relief 
be used to implement a variety of devices. The features system to facilitate the performance of their immunoassay 
including valves and pumps can be flexibly arranged to pro- with small portable systems. This format has been developed 
vide multi-channel lab-on-a-chip instruments that are able to 35 as the Raptor portable analyzer that uses integrated flow sys- 
integrate sample preparation and analysis steps into a single tems and fiber optic biosensor capillaries to analyze four 
device. The microfluidic platform is particularly well-suited different agents in a ten minute operation. The unique char- 
as one device capable of implementing an integrated patho- acteristics of addressable arrays have been recognized to 
gen detection system. develop an integrated stacked microlaboratory that performs 
Conventional rapid pathogen detection systems use detec- 40 automated electric field driven immunocapture and DNA 
tion employing either Enzyme Linked Immunosorbent hybridization array analysis. For example, following immu- 
Assays (ELISA) or Fluorescence Immunoassays (FIA). Typi- nocapture the bacteria were released for strand displacement 
cally, detection involves the immobilization of an analyte amplification (SDA) followed by hybridization analysis of 
specific antibody, incubation with the sample solution, and the amplified Shiga like toxin gene. However, the multiplex 
recognition with a sandwich antibody linked to an enzyme or 45 sample analysis was not performed and the limits of detection 
fluorophore followed by development and detection. Immu- was not studied. 
nofluorescence detection assays have also been used. How- While conventional microfabrication is done in silicon, it 
ever, detection limits associated with each of these assays are has been determined that for chemical and biochemical 
relatively restrictive. analyses, glass microfludic structures exhibit preferable 
The use of various formats of PCR based genetic detection 50 chemical and electrophoretic properties and the extension to 
and typing is also popular because of its high specificity and plastic structures is in progress. In the high throughput appli- 
gain. However, even though DNA based PCR approaches are cations, the techniques of the present invention provide radial 
powerful, they will respond positively to both viable and channel layouts that permit the rapid parallel analysis of 96 to 
nonviable pathogens, potentially producing false positives. 384 fragment sizing or sequencing separations in parallel. 
Detection of RNA targets may be thus preferred because its 55 The integration of PCR directly with CE analysis on a chip is 
rapid degradation means that live targets are required for provided with enzymatic DNA digestion and affinity capture. 
detection. According to various embodiments, the microfluidic 
A variety of alternative detection methods have also been device mechanisms of the present invention allow the cre- 
proposed. Mass spectrometry methods have been developed ation of intricate channel structures that permit the formation 
to detect pathogens, spores, and other bioagents, by detection 60 of complex arrays of chambers, valves and CE analysis chan- 
of neutral lipids, polar lipids and spore specific biomarkers. nels. The small size of these CE channels together with the 
However, though the speed, throughput and portability of the use of cross injectors facilitates the performance of very 
mass spectrometry approach is not obvious and the specificity rapid, high resolution electrophoretic separations. Substan- 
is unproven. tially all operations that have been performed in chromato- 
The detection of spores, for example anthrax, from soil, air, 65 graphic columns or capillaries have also been reduced to a 
etc. is challenging because it is highly infective (an inhaled chip format with decreases in required sample volume and 
dose of 10,000 spores can be achieved in 10 minutes at 10 improved analysis time and sensitivity. 
In some examples, devices utilizing the three-layer design i o  analysis is also being developed. 
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According to various embodiments, the pathogen detec- 
tion system of the present invention has the attributes of 
sensitivity combined with specificity and quantitation to pro- 
vide a particularly useful assay. Many pathogens are infective 
at >lo3 ingested bacteria, but T cholera will not cause symp- 
toms if less than lo5 organisms are orally ingested and for B. 
anthracis much lower levels are considered significant. Iden- 
tifying the strain so that the pathogenic can be distinguished 
from the nonpathogenic, and identifying the presence of spe- 
cific toxins or antibiotic resistance genes can also be critical 
for identifying the threat and determining the treatment. Fur- 
thermore, the ability to determine the concentration or dose of 
bacteria and to report this quantitatively along with the iden- 
tity will distinguish important challenges from background 
challenges. 
FIG. 7 is a diagrammatic representation of one example of 
a pathogen detection system 700. An analyte is introduced 
through a channel 701 into immunoaffinity capture chambers 
703, 713, and 723 with waste collected at a channel 731. 
According to various embodiments, immunoaffinity reagents 
are used to capture, concentrate and stratify input bacterial 
mixtures into the series of separate immunological chambers 
703,713, and 723. This facile process addresses the important 
macro to micro interface that has previously been a barrier for 
the application of microfluidic systems to trace pathogen 
detection. The first stage of immunocapture also plays a sig- 
nificant role in enhancing the specificity of the assay. To 
achieve the enhanced sensitivity, a user of the pathogen detec- 
tion system can then perform PCR based redundant confir- 
mation of the presence of the agent and also develop methods 
based on specific primers or more general genotyping meth- 
ods such as PCR to identify the specific strain, the presence of 
toxin genes and the presence of antibiotic resistance markers 
using DNA analysis mechanisms 705,715, and 725. In one 
example, DNA analysis mechanisms 705, 715, and 725 
include PCR and CE. 
According to various embodiments, the immunoaffinity 
capture chambers 703,713, and 723 are integrated with PCR 
chambers but CE mechanisms remain separate. The combi- 
nation of immunocapture and nucleic acid analysis dramati- 
cally enhances the sensitivity and specificity of the individual 
assays. 
The ability to genetically differentiate pathogenic from 
nonpathogenic strains is critical in many applications. The 
combination of immunocapture as the front end to PCR 
analysis provides an important purification of the input bac- 
terial population to address concerns about the presence of 
PCR inhibitors often found in impure, complex “real world” 
samples. According to various embodiments, the pathogen 
detection system will be set up to perform PCR in the low 
cycle number (not asymptotic) regime so that quantitation of 
the input target population is maintained and reported. In 
many examples, the processed samples can then be provided 
for CE analysis. The use of modem microfluidic technologies 
will result in the production of inexpensive, rapid and robust 
assay systems that are small, portable, and require minimal 
power, resources and skill for operation. 
Integrated immunoaffinity capture chambers are included 
in a pathogen analyzer. A variety of capture mechanisms can 
be used, such as frits, beads, gels, monoliths, and polymers. 
FIGS. 8 and 9 are diagrammatic representations showing 
immunocapture chambers implemented using silica frits or 
beads. According to various embodiments, immunocapture 
chambers includes a series of silica frits fabricated by filling 
wafer holes with a mixture of silica power and sodium silicate 
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binder. Upon dehydration and rinsing, the silicate condenses 
to silica gel and an insoluable silica frit is formed at 801,803, 
805, and 807. 
According to various embodiments, each silica frit formed 
in a 1.1 mm thick glass wafer is 1 mm in diameter. The 
immunocapture chambers are associated with a channel 821 
for introducing and evacuating an analyte. The in-wafer frits 
can easily be integrated into devices containing membranes 
811 and 813 and valve and pump structures. In FIG. 8, the 
four silica frits 801, 803, 805, and 807 are sealed shut by 
membranes 811 and 813. The large silica surface of each frit 
is suitable for chemical derivatization by a wide variety of 
organosilane reagents. To further simplify device fabrication, 
the monolith wafer can be chemically derivatized prior to 
non-thermal PDMS bonding to the rest of the device. 
In one example, mechanisms such as frits or beads 1.5 pm 
are provided into a capture chamber to allow for capture of 
many macro species such as spores and bacteria. Solid-phase 
capture of many macro-species is known to those of skill in 
the art and is well characterized in Weimer, B. C., M. K. 
Walsh, C. Beer, R. Koka, and X. Wang, 2001 Solid Phase 
Capture Of Proteins, Spores, and Bacteria. Appl Environ. 
Microbiology, 67:1300-1307. In some examples, to utilize 
bead reagents for capture, the chamber is modified with a weir 
structure to provide a bead stop, as well as a bead introduction 
channel. Electrokinetic bead bed packing and weir bead trap- 
ping is known to one of skill in the art. Alternatively, immu- 
nofunctionalized magnetic beads may be introduced into a 
chamber without a weir. 
FIG. 9 is a diagrammatic representation showing open 
valves with the monoliths no longer sealed. According to 
various embodiments, pneumatic vacuum pressure is applied 
at regions 901, 903, 905, 907, and 909 to allow flow of an 
analyte along channel 921 through the frits 931,933,935, and 
937. Any number of frits may be included in a fabricated 
device. 
FIG. 10A is a diagrammatic representation showing cap- 
ture of an analyte. According to various embodiments, a 
pump 1000 includingthreemembranevalves 1001,1003, and 
1005 is used to pump an analyte solution containing oligo- 
nucleotides, proteins, cells, etc., through the series of immu- 
nocapture chambers. 
Chambers can use a variety of mechanisms for capturing a 
target of interest. Anything of interest configured for capture 
in an immunocapture chamber is referred to herein as a target. 
The fluid or substance carrying the target is referred to herein 
as an analyte. In one example, the target is Salmonella or 
Listeria carried in a fluid analyte. 
In other examples, each capture chamber is filled with a 
viscous polymeric matrix containing oligonucleotide probes 
to selectively bind the target molecules. In the case of DNA 
analysis, Sanger DNA sequencing extension products, 
including primers and polymerase reagents in a high salt 
concentration, are electrophoresed through an immunocap- 
ture chamber containing the immobilized acrylamide matrix 
containing the covalent oligonucleotide probe. The capture 
sequence is chosen so that only DNA amplification products 
are captured by the probe, but the primers and polymerase 
reagents, along with salts, pass through the device. This is not 
unlike the need to purify target molecules from complex, dirty 
mixtures that will be encountered in point of care analyses. 
An alternative approach for the preparation of microcap- 
ture chambers with functionalized polymeric capture matri- 
ces includes the preparation of monoliths with pores in the 
range of 10-20 pm, and the preparation of chambers with 
large microfabricated elements (ca. 100 pm) surface modified 
by a thin crosslinked layer of functional polymer. This 
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approach is useful as beads are sometimes found difficult to 
pack in capture chambers and bead beds are often not suffi- 
ciently mechanically stable for routine operation. According 
to various embodiments, molded blocks ofporous (10-20 pm) 
surface functionalized polymer monoliths are formed directly 
within the capture chambers by photo polymerization of a 
precursor mixture including monomers and porogenic sol- 
vents. 
Since the polymerization process is accomplished using 
W light, the porous polymer can be formed in any desired 
area of the microfluidic device using photolithography. The 
kinetics of such a “microlithographic” polymerization pro- 
cess using glass chips filled with a precursor mixture has been 
characterized and is known to one of skill in the art as shown 
inYu, C., F. Svec, and J. M. J. Frechet 2000. Towards station- 
ary phases for chromatography on a microchip: Molded 
porous polymer monoliths prepared in capillaries by photo- 
initiated in situ polymerization as separation media for elec- 
trochromatography. Electrophoresis, 21:120-127 andYu, C., 
M. Xu, F. Svec, and J. M. J. Frechet 2002. Preparation of 
monolithic polymers with controlled porous properties for 
microfluidic chip applications using photoinitated free radial 
polymerization. J.  Polymer Sci., 40:755. Similarly the precise 
location of the monolithic material on the device as well as its 
surface chemistry can be controlled as is known to one of skill 
in the art as shown in, Rohr, T.C, C.Yu, H. M. Davey, F. Svec, 
and J. M. J. Frechet 2001. Simple and efficient mixers pre- 
pared by direct polymerization in the channels ofmicrofluidic 
chips. Electrophoresis, 22:3959. Control over porous proper- 
ties of the monolithic polymers can be achieved by adjusting 
the composition of the porogenic solvents. 
Whether a monolith or a surface with microfabricated ele- 
ments is used, the same grafting approach can be used to 
introduce the desired binding elements. Since the goal is to 
immobilize antibodies on the pore surface ofthese monoliths, 
the grafted chemistries are specified to readily react with 
biopolymers. In one example, units of 2-vinyl-4,4-dimethy- 
lazlactone incorporated into a surface graft can react rapidly 
with proteins. Such mechanisms are known to one of skill in 
the art as shown in Peterson, D. S., T. Rohr, F. Svec, and J. M. 
J. Frechet. 2002. Enzymatic microreactor-on-a-chip: protein 
Mapping using trypsin immobilized on porous polymer 
monoliths molded in channels of microfluidic devices. Anal. 
Chem., 74:4081:4088. The surface to be modified (porous 
monolith, or microfabricated elements) can be immersed in a 
monomer solution and the device can be irradiated by W 
light to achieve grafting in preselected areas. The extent of 
surface functionalization is controlled by the concentration of 
the monomer in the reaction solution, the irradiation time, and 
the intensity of the W light. 
In other embodiments, trypsin is immobilized on porous 
polymer monoliths consisting of 2-vinyl-4,4-dimethylazlac- 
tone, ethylene dimethacrylate, and acrylamide or 2-hydroxy- 
ethyl methacrylate. The azlactone functionalities react 
readily with amine and thiol groups of the enzyme to form 
stable covalent bonds. In some examples, the optimized 
porous properties of the monoliths lead to very low back 
pressures enabling the use of simple mechanical pumping to 
carry out both the immobilization of the enzyme from its 
solution and the subsequent analyses of substrate solutions. 
The Michealls-Menten kinetic characteristics of the reactors 
can be probed using a low molecular weight substrate such as 
N-a-benzoyl-L-arginine ethyl ester. 
The effects of immobilization variables such as the con- 
centration of trypsin in solution and percentage of azlactone 
fmctionalitiestles in the in the monolith, as well as the effect 
of reaction time on the enzymatic activity, and of process 
14 
variables such as substrate flow velocity and residence time in 
the reactor, were studied in detail. The proteolytic activity of 
the enzymatic microreactor on chip was demonstrated at dif- 
ferent flow rates with the cleavage of fluorescently labeled 
5 casein used as a substrate. The excellent performance of the 
monolithic microreactor was also demonstrated with the 
digestion of myoglobin as the fast flow rate of 0.5 pL/min, 
which affords a residence time of only 11.7s. The digest was 
then characterized using MALDI-TOFMS, and 102 out of 
10 153 possible peptide fragments were identified giving a 
sequence coverage of 67%. 
An enormous effort has been directed toward the develop- 
ment of new micorfabricated analytical devices and their 
integration to create micro total analytical systems (Ptas). 
l5 These systems offer the promise of increased throughput, 
lower sample and reagent consumption, smaller size, and 
lower operating costs than full size instrumentation, Among 
the various applications of microfluidic devices, analytical 
techniques such as electrophoresis, electrochromatography, 
2o assays involving enzymes, and immuno-assays have already 
been demonstrated in this format. Despite the undeniable 
success of microfluidic chip technologies, some problems 
persist. For example, the vast majority of microfluidic chips 
feature open channel architecture. Consequently, these chan- 
25 nels exhibit rather small surface-to-volume ratios. They may 
be a serious problem in applications such as chromatographic 
separations, solid-phase extraction, and heterogeneous 
catalysis that rely on interactions with a solid surface. Since 
only channel walls can be used to provide the desired inter- 
30 actions, the microdevice can only handle minute amounts of 
compounds. 
FIG. 10B is a diagrammatic representation showing use of 
the two-dimensional analysis system. After the monoliths 
35 1027 capture targets provided by the pump with valves 1001, 
1003, and 1005, the monoliths 1027 are sealed. In one 
example, each chamber is then heated to melt the double 
stranded DNA and drive off the single stranded DNA product. 
According to various embodiments, the purification takes 
4o place in 120 seconds, and a 200 fold concentration to only 20 
nL from an initial volume of 3 pL can be achieved. Each line 
1011,1013,1015,1017,1019, and 1021 includes valves for 
controlling or pumping captured targets for additional analy- 
sis steps. 
In one example, captured targets are provided for PCR and 
CE analysis on the test device. Captured targets can be 
released for DNA analysis using mechanisms such as heat or 
a change in pH. The basic features of such an integrated test 
device include: 1) an immunocapture chamber etched into a 
50 glass substrate with a microfabricated heater and temperature 
sensor; 2) a polymerase chain reaction chamber of 100 300 nL 
for amplification of DNA obtained from lysing the cells of 
interest; and 3) a capillary electrophoresis microchannel 
etched into the glass substrate for separation and detection of 
An optional fourth item, an integrated DNA preconcentra- 
tiodclean-up chamber, can also be added to the device for 
purification of the released pathogen genomic DNA or for 
desalting and preconcentration of the amplified DNA before 
60 injection onto the CE microchannel if needed. Although pre- 
vious studies have shown that PCR amplicons can be directly 
injected onto CE microchannels for successful analysis, 
potentially obviating the necessity of such additional com- 
plexity, such purification may be necessary to obtain high 
65 quality electropherograms. This amplicon purification could 
be enabled by using oligonucleotide capture matrix chemis- 
tries. If it is necessary to purify the genomic DNA, a clean-up 
45 
55 the PCR amplicons. 
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chamber could be filled with carboxylated silica beads and Staphylococcal and & Streptococcal strains. In these cases, 
used as a general capture matrix for bacterial DNA before the use of a separate immunocapture chamber and the addi- 
PCR. tion of a clean-upipreconcentration chamber allows for inter- 
One approach to integration is simply to fabricate immu- mediate capture of DNA after cell lysis but before PCRampli- 
nocapture, template purification, PCR, amplicon clean-up, 5 fication. 
and CE as separate modules on a glass chip. The modules In this scenario, following capture and lysis, the extracted 
would then be interfaced with each other using microchan- DNA can be electrophoretically driven into the cleanup 
nels and various PDMS valve structures. A schematic of a chamber for storage by adsorption to carboxyl beads. The 
pathogen analysis chip configured with separate immunocap- purified DNA can be released from the clean-up chamber 
ture and PCR reactors is presented in FIG. 11. The integrated i o  using heat or variations in ionic strength and electrophoreti- 
pathogen detection system includes an immunoaffinity cap- cally transported into the PCR chamber for amplification. 
ture chamber 1101. An analyte is introduced into the patho- Once the DNA from the lysed cells is presented to the cham- 
gen detection system through the immunoaffinity capture ber with PCR buffer, PCR can be performed directly on the 
chamber 1101.APCR chamber 1103 is coupledto the immu- released genetic material using the microfabricated heater 
noaffinity capture chamber 1101 and receives targets cap- 15 and temperature sensor. 
tured by the immunoaffinity capture chamber 1101. A CE It should be noted that in some instances, the combineduse 
channel 1105 is coupled to the PCR chamber 1103 for further of a single chamber for both capture and PCR is problematic 
analysis. Microfabricated electrodes 1113 are operable to because of complexity or PCR inhibition. In these particular 
provide voltage differentials. A heater (not shown) coupled to instances, the two stages can simply be separated. In some 
the immunocapture chamber and/or the PCR chamber is also 20 examples, this may be done if the presence of the capture 
provided. A variety of valves control the flow an analyte matrix or beads inhibits the PCR reaction or if the input 
through the integrated system. According to various embodi- sample brings in PCR inhibitors that cannot be washed out or 
ments, the valves are monolithic valves. neutralized. In this case, the released DNA could be pumped 
Although providing immunocapture, PCR, CE and clean- or electrophoresed from the lysed bacteria in the capture 
up as separate modules on a device is a reasonable strategy, 25 chamber to a separate PCR reactor for analysis. 
the capture efficiency, PCR efficiency and high sensitivity Upon completion of PCR, the amplicons can be directly 
separation and detection of DNA fragments that are facili- injected onto a CE microchannel for separation and detection, 
tated according to various embodiments suggest that a less either using intercalating dye in the separation matrix or 
complex device can be used. While immunocapture and PCR fluorescently labeled primers and a denaturing separation 
could be performed in separate chambers, in one example, 30 matrix depending on the desired resolution. In some 
immunocapture and PCR can be combined to simplify the instances, a DNA clean-up chamber is introduced to desalt 
device and the process. In this example, PCR can be success- and concentrate the amplified DNA prior to injection onto the 
fully conducted from solid substrates and from solid phase CE microchannel. Clean-up is accomplished by electro- 
immunocapture reagents. In one example, PCR can be per- phoresing the amplified DNA into the clean-up chamber 
formed using immuno-labeled beads. 35 where it is bound to carboxylated beads or to an oligonucle- 
FIG. 12 is a diagrammatic representation showing a com- otide capture matrix (capture oligos complementary to the 
bined immunocapture and PCR chamber 1201. According to desired targets). Binding followed by washing and tempera- 
various embodiments, the combined chamber has integrated ture dependent release using a micro heater is followed by 
resistance heating mechanism (not shown) and a resistance electrophoresis of the concentrated and desalted PCR ampli- 
temperature detector (RTD) 1205 fabricated within the nano- 40 cons through the injection cross of the CE microchannel for 
liter chamber. In some examples, an analyte is introduced separation and detection. 
through an input 1211 through a membrane valve 1221. The device configuration for using monolithic membrane 
Pathogens of interest are immobilized within the chamber valves to build a pathogen detection and analysis system can 
1201 using pressure driven flow and waste is collected be varied substantially. FIG. 13A is a diagrammatic represen- 
through a valve 1223 at an output 1213. After pathogens are 45 tation showing one example of a design for the pathogen 
immobilized, the chamber 1201 is flushed with buffer to detection and analysis system. The design includes three 
remove loosely adhered cells or non specifically bound glass layers, including a channel layer 1303, a via layer 1305, 
agents. and a manifold layer 1309. A PDMS membrane layer is 
PCR buffer is introduced either through the original sample provided between a via layer 1305 and a manifold layer 1309. 
inlet 1211 or through a separate dedicated inlet Depending on 50 The manifold layer 1309 includes mechanisms allowing 
the pathogen of interest in the chamber 1201, a chemical lysis vacuum pressure to be applied to the membrane 1307 to allow 
agent can be included directly into the PCR buffer. After control of valve mechanisms. 
introduction of the lysis reagent and/or PCR buffer, the inte- Electrical connections are provided on a layer 1301 and a 
grated heater 1203 in the captureiPCR chamber is used to manifold chuck layer is included at layer 1311. The channel 
raise the temperature of the sample to a temperature at which 55 layer 1303 includes the immunocaptureiPCRlclean-up cham- 
the pathogens are simultaneously released from the capture bers and CE microchannels; as well as the heaters on the top 
matrix and, depending on the class of agent, lysed. surface of the wafer. According to various embodiments, the 
The simplest and often most effective lysis method is sim- channel layer 1303 is thermally bonded to a thin glass wafer 
ply performing heatingicooling cycles. Gram negative bacte- 1305 containing drilled glass holes that act as valve vias. A 
ria and some eukaryotic cells, with their thinner outer mem- 60 PDMS valveipump membrane 1307 is either reversibly or 
branes, are more susceptible to lysis using either heat alone or irreversibly bonded to this multiple layer stack. The bottom 
heat with a small concentration of chemical lysis solutions. In etched manifold layer 1309 conveys vacuum or pressure to 
some cases, such as for spores or gram positive bacteria, use the valves and pumps on the device. 
of a more aggressive lysis agent that would interfere with the The use of existing thin film technology to create the tem- 
PCRmay be necessary. For example, lysozyme, proteinase K, 65 perature control elements presents a viable first approach to 
lysostaphin, and mutanolysin are commonly required sepa- construction of test devices. However, the fabrication com- 
rately or in tandem to lyse some recalcitrant gram positive plexity of the device can be reduced through the use of indium 
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tin oxide (ITO) heaters. IT0  heaters are noted, for their low The parallelization of the fluidics control systems, electrical 
resistivity, optical transparency, and compatibility with glass circuitry for heaters, temperature sensors and electrophoresis 
substrates. These heaters can be deposited on the same wafer for three systems is straightforward and a single microscope 
as the temperature sensors, obviating the need for backside slide has sufficient surface area to fabricate three fully parallel 
fabrication and electroplating to form the heaters. The heaters 5 systems. 
can be placed directly within the chambers for optimal ther- In another example, a massively parallel immunocapturei 
mal transfer or they can be placed against the chambers to PCR system for use in clinical diagnostics is provided. The 
conduct thermal energy through a glass wafer. The optical ability to analyze multiple distinct agents across multiple 
transparency of IT0 also allows routing of electrical heater individuals or groups of individuals provides a powerful 
leads over fluid microchannels without interfering with visu- i o  method for identifying and epidemiologically tracking infec- 
alization or detection of sample or PCR amplicons. tious agents. FIG. 14 is a diagrammatic representation of a 
FIG. 13B is a diagrammatic representation showing a portion of a radially parallel immunocaptureiPCR device 
microfabrication process according to various embodiments. 1400. Any system or device having multiple immunocapture 
Microfabrication processes are shown at 1381 and 1383. In and DNA analysis mechanisms arranged about a circular axis 
some examples, glass wafers (550 pm thick D263 available 15 is referred to herein as a radially parallel device. 
from Schott of Yonkers, N.Y.) are cleaned before sputter According to various embodiments, the design includes an 
deposition of a 2000 8, layer of amorphous silicon on one side array of pairs of analyzers each of which includes a unique 
by DC magnetron sputtering available from UHV Sputtering immunocaptureiPCR chamber 1423 integrated with a CE 
of San Jose, Calif.). Photoresist available from Shipley 1818 analyzer. The sample travels serially through all chambers 
of Marlborough, Mass. is spun on and photolithographically 20 within a given subset of the device, allowing for serial capture 
patterned using a contact aligner available from Karl Suss of of multiple agents. Separate subsets 1401,1403,1405,1407, 
Waterbury Center, Vt. and the underlying silicon etch mask 1409, 1411 of the device are capable of analyzing different 
can be selectively removed using SF6 in a parallel-plate reac- substances in parallel. Reservoirs 1447 and 1445 provide 
tive ion etching (RIE) system available from Plasma Therm of bead input and bead waste. Reservoirs 1443 and 1441 are the 
St. Petersburg, Fla. 25 common capillary electrophoresis cathode reservoir and 
In some examples, the fluidic channels, electrophoresis waste reservoir, respectively. 
channels, and PCR chambers are etched to a depth of 36 pm The chambers are interconnected for cascaded immunoaf- 
in 49% hydrofluoric acid. Reservoir access holes (1.5 mm finity capture. Valves 1431 and 1433 seal the chamber on the 
diameter) and fluidic via holes (0.020" diameter) for the cascade loop. Valves 1435 and 1437 seal the chamber from 
PDMS valves are drilled using a CNC mill available from 30 bead introduction and waste channels. CE microchannels are 
Flashcut CNC of Menlo Park, Calif. with diamond-tipped connected to a common central anode for detection using a 
drill bits. The wafer is then diced using a wafer dicing saw to proven rotary confocal fluorescence scanner (not shown). A 
form two 20 mmx75 mm slides. parallel array of combined capture chambers 1423 and heat- 
To form the RTDs and electrodes, a 550 pn-thick D263 ers with leads 1451 and the development of robust arrays of 
wafer can first be sputtercoated with 200 8, of Ti and 2000 8, 35 valves and pumps are provided. Since the heaters and tem- 
of Pt (UHV). Thick photoresist available from Shipley (SJR perature sensors associated with chambers 1423 are operating 
5740) of Marlborough, Mass. is spun on and patterned using in parallel on the analysis channels, the use of simple ring 
a contact aligner available from Suss Microtec of Waterbury heaters are more than adequate. Thus the individual heaters 
Center, Vt. According to various embodiments, the photore- and temperature sensors are no longer necessary for provid- 
sist is hard baked at 70" C. for 2 hours. The metal can be 40 ing an efficient and effective parallel pathogen detection sys- 
etched using hot aqua regia (3: 1 HCI:HN03, 90" C.) to form tem 
the RTD elements. The integrated heaters are formed by first Although many of the components and processes are 
depositing a multi-layer thin film of 200 8, of Ti and 2000 8, described above in the singular for convenience, it will be 
of Pt on the backside of the RTD wafer using RF sputtering appreciated by one of skill in the art that multiple components 
available from Perkin Elmer of Wellesley, Mass. Thick pho- 45 and repeated processes can also be used to practice the tech- 
toresist is spun on the side, the wafer is patterned using a niques of the present invention. 
backside contact aligner (Suss), and hard baked. Gold is While the invention has been particularly shown and 
electrodeposited onto the TiiPt seed layer at 4.3 d c m 2  for described with reference to specific embodiments thereof, it 
23 minutes to a 5 pm thickness using a gold sulfite plating will be understood by those skilled in the art that changes in 
solutionavailable fromTechnic (TG25 E) ofAnaheim, Calif. 50 the form and details of the disclosed embodiments may be 
to form the heater leads. made without departing from the spirit or scope of the inven- 
According to various embodiments, the photoresist is tion. For example, the embodiments described above may be 
removed and the backside is re-patterned using thick photo- implemented using a variety of materials. Therefore, the 
resist. The heating elements are etched into the TiiPt seed scope ofthe invention should be determined with reference to 
layer using an ion beam etching system available formVeeco 55 the appended claims. 
Instruments of Plainview, N.Y. The RTDiheater wafer is diced What is claimed is: 
into two 25 mmx75 mm slides (Disco). In some examples, the 1. A microfluidic structure comprising: 
drilled channel wafer is thermally bonded to the RTDiheater a plurality of diaphragm valves that control fluid flow along 
wafer using a programmable vacuum furnace available from each of a plurality of fluidic channels, said fluidic chan- 
CenturionVPM, J. M. Ney, ofyucaipa, Calif. nels each comprising a discontinuity and wherein the 
Although, a single immunocapture, PCR, and CE system microfluidic structure comprises an elastomer mem- 
can be included on a substrate, the techniques of the present brane sandwiched between a pneumatic layer and a flu- 
invention recognize that it may be efficient to develop a par- idic layer, wherein: 
allel immunocapture, PCR, and CE system for use in clinical the pneumatic layer comprises a first surface including at 
diagnostics. In one example, a portable pathogen analyzer 65 least one pneumatic channel facing the membrane and 
includes three serial immunocaptureiPCR systems targeted valve areas aligned with said fluidic channel disconti- 
towards the detection ofthree different pathogens in a sample. nuities; 
60 
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the fluidic layer comprises a second surface including the 9. The microfluidic structure of claim 7 configured as a 
plurality of fluidic channels facing the membrane; mixer, wherein the input valves and output valves ofthe pump 
the elastomeric membrane normally prevents fluid flow are each connected to admission channels to form a mixer 
across the fluidic channel discontinuities; and wherein mixing is accomplished by actuating the three dia- 
a vacuum to the at least one pneumatic channel causes the 5 phragms in a sequence to pump the fluid in a loop or back and 
membrane to deflect to allow a flow of a fluid across the forth. 
fluidic channel discontinuities, thereby forming the plu- 10. The microfluidic structure of claim 1 wherein the pneu- 
rality of diaphragm valves. matic layer comprises a pneumatic channel comprising a 
2. The microfluidic structure of claim 1, wherein the first displacement chamber wherein deflection of the membrane 
and second layers are glass. i o  forms a fluid reservoir in the fluidic channel. 
3. The microfluidic structure of claim 1, wherein the mem- 11. The microfluidic structure of claim 10, whereinmixing 
brane is gas permeable. is accomplished by moving a fluid between two reservoirs. 
4. The microfluidic structure of claim 1, further comprising 12. The microfluidic structure of claim 10, wherein reser- 
additional surfaces and membranes in fluidic communication voirs in each of a plurality of the fluidic channels are con- 
with the microfluidic structure through a plurality of vias. 
5. The microfluidic structure of claim 4, wherein the addi- 13. The microfluidic structure of claim 10, wherein the 
tional surfaces have additional channels to provide paths for reservoir has one or more inputs and is operable as a reactor. 
fluid flow. 14. The microfluidic structure of claim 1 wherein one 
6. The microfluidic structure of claim 1, wherein the fluidic pneumatic channel actuates a plurality of diaphragm valves 
layer includes a plurality of vias operable to provide paths for 20 that control fluid flow in a plurality of different fluidic chan- 
fluid flow through the fluidic layer. nel s . 
7. The microfluidic structure of claim 1 configured as part 15. The microfluidic structure of claim 1 wherein different 
of one or more pumps, wherein each pump comprises three pneumatic channels each actuate a diaphragm valve that con- 
diaphragm valves in series and comprising an input valve, a trols fluid flow in different fluidic channels. 
displacement valve, and an outlet valve, wherein each dia- 25 16. The microfluidic structure of claim 1, wherein the first 
phragm valve is actuated by a different pneumatic channel and second layers are plastic. 
and the three diaphragm valves are independently activated in 17. The microfluidic structure of claim 1 wherein the mem- 
a sequence designed to move fluid through the pump. brane is PDMS. 
8. The microfluidic structure of claim 7, wherein one or 18. The microfluidic structure of claim 1 wherein the pneu- 
more of the pumps is used to form a multi-directional fluidic 30 matic layer further comprises one or more pneumatic ports to 
router, said router comprising one central displacement valve 
in fluid communication with one or more input valves and one 
or more outlet valves. * * * * *  
15 nected by a fluidic bus. 
supply vacuum to the pneumatic channel. 
